A B S T R A C T The effect of perfusion of an isolated rat liver on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase was studied. In liver removed during the basal period of the diurnal cycle of enzyme activity, a 227±41% increase in enzyme activity occurred after 3 h of a l)lasna-free perfusion. This could be prevented by the addition of cycloheximide or pure cholesterol (dispersed with lecithin) to the perfusate. In contrast, the continuous addition of taurocholate or taurochenodeoxycholate, alone or in combination, at a variety of rates did not prevent the increase in enzyme activity. The added bile salts were efficiently extracted from the perfusate and excreted in the bile. The addition of these bile salts to a cholesterol-enriched perfusate did not alter the effect obtained with cholesterol alone.
INTRODUCTION
Despite intensive investigation, our understanding of the mechanism of the regulation of hepatic cholesterol synthesis remains incomplete. A large number of sterols, lipids, lipoproteins, hormones, and drugs, as well as age, sex, diet, and time of day, have been shown to affect the rate of hepatic cholesterol synthesis (2) . It has been firmly established that chronic feeding of bile salts reduces the rate of cholesterol formation by liver (3) . However, in vivo there are complex interactions between many of the proposed regulators of cholesterol synthesis (4) , and it is often difficult to ascertain whether a substance directly regulates cholesterol synthesis or creates its effect by altering another aspect of cholesterol metabolism. Moreover, the older method for assessing the rate of cholesterol synthesis has been criticized, and several alternative methods have been developed (5) (6) (7) . Good agreement has been found between measurement of the overall rate of cholesterol synthesis and the activity of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) 1 reductase, the rate-limiting enzyme of cholesterol synthesis (8) . Accordingly, measurement of the activity of HMG CoA reductase in isolated cell preparations has been increasingly utilized to identify the direct regulators of cholesterol synthesis (9, 10) .
Chenodeoxycholate, a bile salt, is being used successfully to dissolve cholesterol gallstones in man (11) . The mechanism for its effect on bile composition is unknown. It may be the result of direct regulation of the activity of hepatic HMG CoA reductase by chenodeoxycholate (12) ; however, the effect may be mediated by bile saltinduced alteration of another aspect of cholesterol metabolism.
Liersch et al. (13) have previously used the isolated perfused liver to demonstrate that neither cholate nor taurocholate inhibits the rate of hepatic cholesterol synthesis. Further use of this preparation seems an excellent way to resolve the question of whether all bile salts, taurochenodeoxycholate alone, or only cholesterol is the sterol component of bile that primarily regulates the rate of hepatic cholesterol synthesis. Accordingly, we have studied the regulation of HMG CoA reductase in the isolated perfused liver (1).
METHODS
Materials. Cholesterol was purchased from Calbiochem (San Diego, Calif.) and recrystalized twice from hot glacial acetic acid. No impurities were detected by thin layer chromatography (silica gel H with benzene: ethyl acetate (1:1, vol: vol)) and by gas-liquid chromatography (1% XE 60 on Gas-Chrom Q [Applied Science Laboratories, Inc., State College, Pa.] at 2100C). Taurocholate and taurochenodeoxycholate were purchased from Calbiochem and recrystalized by the method of Pope (14) . Pure L-a-lecithin was purchased from Grand Island Biological Co. (Grand Island, N. Y.), radioactive materials from New England Nuclear (Boston, Mass.), and Mylar-backed silica gel G chromatography sheets from Eastman Kodak Co. ( In experiments to assess change of hepatic HMG CoA reductase activity, the caudate lobe of the liver was removed at the start of a perfusion and the HMG CoA reductase activity compared with that from a sample of the same liver removed after perfusion.
Because the report of Barth et al. (19) suggested that regional differences in cholesterol synthesis are found after liver perfusion, HMG CoA reductase activity was assayed in multiple sections of the same liver. In unperfused livers the SE was 5±2%o of the mean and in perfused livers the SE was 9±2%o of the mean. Since this degree of variation is not sufficient to affect the results, multiple liver samples were not assayed routinely.
Chemical methods. Cholesterol-phospholipid liposomes were prepared by dissolving cholesterol and phospholipid in chloroform, evaporating the chloroform, adding 0.9% NaCl, submerging the solution in ice, and sonicating with a Branson sonifier (Branson Instruments Co., Stamford, Conn.) for four periods of 2 min each (20) . The resultant suspension was centrifuged at 30,000 g for 30 min and the supernate used. Lipids were extracted from liver perfusate or homogenate by the method of Folch et al. (21) . Cholesterol was measured by the method of Zlatkis et al. (22) , and protein was measured by the method of Lowry et al. (23) . Aspartate amino transferase activity was estimated with a serum glutamic oxaloacetic transaminase Stat Pak (Calbiochem). Statistical significance of results was determined by either paired or grouped t test (24) .
RESULTS
Uptake and excretion of bile salt by isolated perfused liver. The liver not only synthesizes bile salts but also efficiently removes them from blood and excretes them in bile. Thus, if the isolated liver is to be a useful system for the study of bile salt regulation of hepatic cholesterol synthesis, bile salts must be handled by it as they are in vivo. To assess the ability of isolated liver to ex- Time (min) FIGURE 1 Uptake and excretion of bile salts by the isolated perfused liver. Livers were perfused in situ with a medium containing red blood cells, albumin, glucose, and Krebs bicarbonate buffer. ["4C]Taurocholate was added continuously at the rate of 7 mg/100 g rat per h. Samples of perfusate were removed just before and just after passage through the liver and bile was collected via an indwelling bile duct cannula. The samples were assayed for radioactivity as described under Methods. Results are means±SE; n = 5. tract and excrete bile salts, radiolabeled taurocholate was added continuously to the perfusate, at ithe rate of 7 mg/h per 100 g rat. Samples of the portal and hepatic vein perfusate were assayed for radioactivity, and the percent of bile salt extracted per transhepatic passage wvas calculated. The results are shown in Fig. 1 . The efficiency of bile salt extraction from perfusate was about 75% per passage during the first 2 h and then began to decline variably, falling to 54+10% at 2.5 h and 40±12% at 3 h. The rate for the first 2 h approaches the 90% extraction rate reported for liver in vivo (25) . The difference may be due to the higher perfusate flow rate used in isolated liver, which could result in solute streaming (26) . Nevertheless, a steady-state perfusate concentration is quickly achieved, and since this concentration is higher than the normal portal venous bile salt concentration, the net bile salt extracted per passage is similar to that in vivo. The decrease in function that occurred between 2 and 3 h was variable and is consistent with other data2 (27) suggesting that 3 h of perfusion represents the upper limit of usefulness of this preparation.
To insure that the extracted bile salts behave analogously to bile salts in vivo, their rate of appearance in the bile produced by the isolated liver was measured. It is apparent from the data in Fig. 1 that they are excreted rapidly in bile and that the added bile salts efficiently traverse the hepatocyte with almost quantitative biliary excretion. This is similar to their metabolism in vivo. The fall of the percent of total administered bile salt excreted after 2.5 h was a function of the diminished bile flow, usually apparent during the last 30 min of the perfusion; this was not secondary to a decrease in the bile salt concentration of the bile.
Taken together, these data demonstrate that the transhepatic flux of bile salt in the isolated liver is qualitatively and quantitatively similar to that in vivo and provides support for the use of this system for the purposes outlined.
Effect of liver perfusion on hepatic HMG CoA reductase. The liver of rats sacrificed 3 h after the onset of the light phase of the diurnal cycle (10 a.m.) were perfused with a plasma-free buffer and the HMG CoA reductase activity of the liver was measured after 1, 2, or 3 h of perfusion. As shown in Fig. 2 FIGURE 2 Effect of liver perfusion on hepatic HMG CoA reductase. HMG CoA reductase activity was determined in liver before (0) and after 1, 2, or 3 h of perfusion with the medium described in Fig. 1 . Results are shown on the solid line. On the dotted line, the hepatic HMG CoA reductase activity of rats sacrificed at 10 a.m. and 1 p.m. is shown (in vivo). Results are means±SE, n =3 except 0-h n = 8 and 3-h isolated liver n = 5.
little change in enzyme activity is seen in vivo (Fig. 2 , dotted line).
The rise in enzyme activity was prevented by the addition of cycloheximide to the perfusate (Table II) . These findings are consistent with the hypothesis (9, 10) that plasma contains a factor (s) that represses HMG CoA reductase activity by altering the rate of new enzyme synthesis.
Effect of bile salt addition on hepatic HMG CoA reductase. To test the hypothesis that bile salts directly repress HMG CoA reductase activity (28), taurocholate was added continuously to the perfusate at a rate approximating the normal bile salt return to the liver (8 mg/100 g rat per h) (12) . After 3 h of perfusion with bile salt addition, there was no difference in the reductase activity of control perfused livers and those receiving bile salt infusion (Table II) . Similar results (Table II) (Table II) . This high and unphysiologic rate was chosen to insure that transhepatic bile salt flux vould be greater than normal. That this must be the case is apparent from the data in Fig. 2 , where it is shown that 80% of infused bile salt has been excreted by 2.5 h so that the transhepatic flux was at least 11 mg/h per 100 g rat.
It can be seen from the results in Table II HMG CoA reductase activity was determined in samples of the same liver before and after liver perfusion. Perfusate is described in Fig. 1 . Bile salts were added continuously at rate specified or cycloheximide was added in the concentration specified. Means+SE. * Paired t test; NS, not significant. FIGURE 3 Effect of perfusion at the peak of the diurnal cycle on HMG CoA reductase. The procedure described in Table II for the plasma-free perfusate was used, except the perfusions were begun at the middle of the dark phase (midnight). Means+SE; n = 4. The effect of bile salt and cholesterol at the peak of the diurnal cycle. HMG CoA reductase was determined before and after a 3-h perfusion of liver isolated at the middle of the dark period. The perfusate is described in Fig. 1 . Taurocholate (TC) was added continuously at the rate of 8.5 mg/1OO g rat per h. Taurochenodeoxycholate (TCDC) was added continuously at a rate of 12.5 mg/100 g rat per h. Cholesterol was added as described in Table  III . Percent change was calculated as in Table II . Only in the cholesterol-perfused liver was the change in reductase during perfusion significant, P < 0.02. Means±-SE; n = 4.
As shown in Table III , bile salt addition again had no effect on HMG CoA reductase activity. These results demonstrate that HMG CoA reductase activity of isolated liver is subject to regulation by the l)erfusate content, substantiating the usefulness of this model for the study of hepatic cholesterol synthesis. Moreover, they show that pure cholesterol, in the absence of associated sterols or lipoproteins, is capable of altering the activity of hepatic HMG CoA reductase in the intact isolated liver.
HMIG CoA reductase regulation in liver isolated at the middle of the dark phase. Cholesterol synthesis and HMG CoA reductase activity varies with the time of day and reaches a peak at the middle of the dark period (midnight) (29) . Since bile salt regulation of cholesterol synthesis has been reported to be most pronounced during the dark period (28), rat livers were isolated at the midpoint of the dark phase and perfused with the plasma-free perfusate. In contrast to the results obtained with livers from the basal period, enzyme activity was essentially unchanged during a 3-h perfusion (Fig. 3,  solid line) . However, since enzyme activity decreases in vivo during this period (Fig. 3, dotted When bile salts were added to the perfusate during the dark period, no inhibition of HMG CoA reductase activity occurred (Fig. 4) . This was true both for taurocholate and taurochenodeoxycholate infused at basal and suprabasal rates. In contrast, if the perfusate was enriched with cholesterol, the HMG CoA reductase activity declined by 52+4% (Fig. 4) . This is a change of the same magnitude as occurs in vivo during this period (Fig. 3) (Table IV) . * Post differs significantly from pre, P < 0.05. $ Post differs significantly from pre, P < 0.02. 11.6±0.6t
Bile salt-enriched perfusate (n = 6) 10.4±0.3
The hepatic cholesterol content was determined in unperfused liver and in liver after perfusion with various buffers. It is expressed as micrograms cholesteroLper milligram protein to eliminate the potential effect of liver perfusion on hepatic weight. * Differs significantly from unperfused liver, P < 0.02. t Differs significantly from liver perfused without cholesterol, P < 0.05.
Notably, the magnitude of the increase with perfusion in this series of experiments is somewhat less than that in comparable groups of livers perfused with plasma-free medium (Table II) . This is not surprising since plasma contains cholesterol, which should inhibit the enzyme activity. That this effect is not more pronounced could be due either to the presence of hormonal stimulators of HMG CoA reductase or to inefficient uptake of lipoprotein cholesterol by the isolated liver. Since bile salts are also ineffective in altering HMG CoA reductase activity in the more physiologic milieu afforded by a whole-blood perfusate, these results strengthen the conclusion that bile salts are not direct regulators of hepatic cholesterol synthesis.
Effect of liver perfusion on hepatic cholesterol content.
The total cholesterol content of unperfused liver and of liver subjected to a variety of perfusates is shown in Table V . Perfusion with the control buffer resulted in a small but significant decrease in the hepatic total cholesterol content (Table V) , probably the result of cholesterol excretion, both -via lipoproteins and bile. The addition of cholesterol to the perfusate prevented this decrease (Table V) . If this decrease in hepatic cholesterol content was the cause of the increase in HMG CoA reductase activity, the liver is very sensitive to this stimulus, since the cholesterol content fell less than 10% after 3 h of perfusion. DISCUSSION In 1950 Gould and Taylor (33) reported that cholesterol feeding resulted in decreased hepatic cholesterol synthesis. Subsequently, research has estabilshed that cholesterol from intestine, carried in chylomicrons, is removed from the circulation by the liver (34) . This results in an increase in the hepatic content of esterified cholesterol accompanied by a fall in hepatic cholesterol synthetic rate (35) .
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The intracellular events that lead to the decreased rate of synthesis are incompletely understood. It has been established that under most circumstances the overall rate of hepatic cholesterol synthesis is controlled by the rate of reductive deacylation of HMG CoA to form mevalonic acid by the enzyme HMG CoA reductase (36) . In general, this enzyme's activity is proportional to the quantity of enzyme present and this is determined primarily by changes in the rate of enzyme synthesis (31) . Recent evidence suggests that inactivation of the enzyme by proteins (37) , sterols (38) , and ATP (39) may also occur. Kandutsch and Chen (40, 41) have suggested that cholesterol itself does not regulate the activity of H1MG CoA reductase but that certain oxygenatecl or hydroxylated degradation products of cholesterol are the active regulators.
The role of bile salts in this process is unclear. The rel)ort of Bleher and Baker (3), followed by numerous coufirmations, has established that chronic bile salt feeding reduces the rate of hepatic cholesterol synthesis. However, bile salt feeding also increases the rate of cholesterol absorption (42) , decreases the rate of cholesterol catabolism to bile salt (43) , and increases the rate of cholesterol excretion (44) . The net result is almost always an increase in hepatic or serum cholesterol content or both (45) . Moreover, after bile duct obstruction, the rate of cholesterol synthesis increases (46) , despite an increase in hepatic bile salt content (47) . Thus, the bile salt effect could well be mediated by the other changes in cholesterol metabolism. Although experimental confirmation is lacking, the hypothesis that bile salts, especially chenodeoxycholate, are direct regulators of HAMG CoA reductase has been evoked to explain the effect of bile salt feeding on cholesterol synthesis and bile composition (12) . This question is of timely interest because of the recent use of chenodeoxycholate for the dissolution of gallstones ( 1 1).
Attempts to evaluate the ability of bile salts to act as independent regulators of hepatic cholesterol synthesis in rats in vivo have led to contradictory conclusions. Weis and Dietschy (48) diverted the bile of rats and thus eliminated both bile salt and cholesterol absorption.
They then replaced either bile salts or chylomicrons containing cholesterol and found that bile salts could not reduce hepatic cholesterol synthesis but the cholesterol preparation could. Hamprecht et al. (28) diverted the lymph and hence any absorption of cholesterol, and fed bile salts to these rats. They found that cholic acid feeding under these circumstances was effective in reducing the level of hepatic H1MG CoA reductase. Shefer and associates (12) , using a variety of bile salts and dietary manipulations in long-term feeding experiments, tentatively concluded that taurochenodeoxycholate rather than taurocholate might have a direct effect on hepatic HMG CoA reductase in the rat. No explanation is readily available for the discrepancies in the conclusions reached in these reports.
Because of the difficulties involved in trying to control all of the interrelationships between cholesterol and bile salt metabolism in vivo, it is apparent that isolated cell or organ systems are necessary to answer this question. Previous work with in vitro systems has been incomplete. It has been reported that bile salts do not alter the rate of hepatic cholesterol synthesis or HMG CoA reductase activity when incorporated in the medium used to culture human (9) or mouse fibroblasts (40) , fetal mouse liver cells (48) , or adult rat hepatocytes.3 Because it allows the investigator to control the composition of the blood reaching the liver, the isolated perfused liver appears to be an excellent system in which to resolve this question. This system first used by Liersch et al. (13) In our experiments, the isolated perfused rat liver was also utilized as a model system. The advantage of this approach was that it provided almost complete control of the composition of the hepatic inflow, as well as control of the quantity of bile salt being transported from the perfusate, through the hepatocyte, into the bile. Moreover, because of the short half-life of the enzyme H1MG CoA reductase (30, 31) , significant changes in its activity can be measured within the period of the liver's viability. Neither taurocholate nor taurochenodeoxycholate, alone or in combination, could affect the activity of HMG CoA reductase, despite infusion at a variety of rates, both physiologic and supraphysiologic. The latter rates were chosen to insure that the amount of bile salts traversing the hepatocytes would be greater than in the normal liver, and in some instances would be in the range achieved with chronic bile salt feeding. In addition, because of the known diurnal variation in the rate of hepatic cholesterol synthesis (29) , experiments were carried out in livers isolated both at the height and at the nadir of this circadian rhythm. Although hepatic HMG CoA reductase responds somewhat differently to 'Bissell, D. M. Personal communication.
Regulation of HMG CoA Reductase in the Isolated Perfused Liver perfusion at these time periods, no effect of bile salt on enzyme activity was discerned in either group of experiments. Finally, to insure that the lack of bile salt effect was not the result of the perfusate composition, experiments were carried out with a plasma-free-cholesterol-poor perfusate, a plasma-free-cholesterol-enriched perfusate, and a plasma-containing perfusate. Again, although hepatic HMG CoA reductase responds differently to these perfusates, no effect attributable to bile salt addition occurred. The possibility that a primary or secondary bile salt ordinarily present in trace amounts in the bile is a regulator of cholesterol synthesis is not excluded by these data. We must conclude, however, that neither taurocholate nor taurochenodeoxycholate is a direct regulator of hepatic HMG CoA reductase and that the effect of bile salt feeding on hepatic cholesterol synthesis seems to be mediated by another effect of bile salt on hepatic cholesterol metabolism.
The finding that small changes in hepatic cholesterol content occur reciprocally with change in cholesterol synthesis suggests that these changes (49) or perhaps the cholesterol content of some intracellular compartment (50) may ultimately mediate the bile salt effect. That this was not noted in all studies of bile salt feeding ( 12) may be due to the fact that a large number of animals must be studied before such small changes become statistically significant. Moreover, in chronic feeding experiments, sufficient time may elapse before the measurement of cholesterol content to allow a return to homeostasis with the achievement of near-normal hepatic cholesterol levels (12, 51) .
It is also clear from our results that highly purified cholesterol, in the absence of significant amounts of other sterols or lipoproteins, is capable of suppressing hepatic HMG CoA reductase activity. While this does not by any means establish that the infused cholesterol itself is the final mediator, it does indicate that cholesterol alone is sufficient to initiate the chain of events leading to the inhibition of hepatic cholesterol synthesis.
The difference in response of hepatic H1IG CoA reductase to perfusion with plasma-free and whole-bloodcontaining buffers is of note. That perfusion of isolated liver with a plasma-free medium results in an increase of hepatic cholesterol synthesis is not surprising in light of the findings of others. It is probable that this response in isolated liver is similar to the stimulation of HAIG CoA reductase that occurs when fibroblasts (9), hepatoma cells (10) , or rat hepatocytes (52) are cultured in plasma-free medium. However, in contrast to these isolated cell systems, the addition of whole plasma to the perfusate only partially prevented the stimulation. This suggests that the inhibitory factor in plasma is present in limited quantity and may require the presence of peripheral tissues for its activation or continuous supply. This speculation is consistent with our current understanding of chylomicron metabolism (53) .
The different response of liver to perfusion at the height and at the nadir of the diurnal cycle of cholesterol synthesis was of note. Perfusion of liver isolated at the basal period of synthetic activity results in an increase in enzyme activity, and the inclusion of inhibitors of protein synthesis or of HMIG CoA reductase, such as cycloheximide or cholesterol, prevents this rise. However, neither inhibitor was able to cause a reduction of HXIG CoA reductase activity below the initial level. In contrast, liver perfused at the height of the circadian rhythm of synthetic activity did not respond with an increase in HMG CoA reductase activity. Rather, the already high level of enzyme activity was maintaine(l when it wvould otherwise have begun to decrease. The presence of cholesterol at this time caused a marked fall in enzyme activity and the magnitude of decrease was consistent with the rate of decline of activity expected with the cessation of new enzyme synthesis. These results raise the possibility that different systems of control of enzyme activity may be operative during these different periods in the circadian rhythm.
